1-2 of 2
Jonathan Landa
Close
Sort by
Journal Articles

Phase I First-in-Class Trial of MCARH109, a G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D) Targeted CAR T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma

Sham Mailankody, Claudia Diamonte, Lisa Fitzgerald, Peter Kane, Xiuyan Wang, Devanjan S. Sikder, Brigitte Senechal, Vladimir P. Bermudez, Diana Frias, Justina Morgan, Patrick Grant, Terence J Purdon, Kinga Hosszu, Sean M Devlin, Urvi A Shah, Jonathan Landa, Alexander Lesokhin, Neha Korde, Hani Hassoun, Carlyn Tan, Malin Hultcrantz, Gunjan L. Shah, Heather J Landau, David J. Chung, Michael Scordo, Mikhail Roshal, Ola Landgren, Ahmet Dogan, Sergio A Giralt, Jae H Park, Isabelle Rivière, Renier J Brentjens, Eric L Smith
Journal: Blood
Blood (2021) 138 (Supplement 1): 827.
https://doi.org/10.1182/blood-2021-153204
Published: 2021
Journal Articles

A Pilot Study Evaluating Lenalidomide and CC-486 in Combination with Radiotherapy for Patients with Plasmacytoma (LENAZART study)

Urvi A Shah, MD, Kelly Werner, RN, Elizabet Tavitian, BS, Sean Devlin, PhD, Sham Mailankody, MBBS, Neha Korde, MD, Malin Hultcrantz, MD PhD, Carlyn Tan, MD, Sydney X. Lu, MD PhD, Eric L Smith, MDPhD, Francesco Maura, MD, Dhwani Patel, MD, Gunjan L. Shah, MDMS, Oscar B Lahoud, MD, Michael Scordo, MD, Richard J Lin, MDPhD, Parastoo B. Dahi, MD, Heather J Landau, MD, David J. Chung, MD PhD, Hani Hassoun, MD, Jonathan Landa, MD, Bernard O'Malley, Christopher Barker, MD, Taha Merghoub, PhD, Sergio A. Giralt, MD, Ola Landgren, MD PhD, Joachim Yahalom, MD, Alexander M. Lesokhin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–10.
https://doi.org/10.1182/blood-2020-141131
Published: 2020